Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1092 results

PHARMAC in negotiations over rare disorders medicines

27-02-2015

New Zealand’s Pharmaceutical Management Agency, PHARMAC, is in active negotiations with several suppliers…

FinancialHealthcareNew ZealandPharmaceuticalPricingRare diseases

BIA welcomes UK’s R&D tax credit scheme

BIA welcomes UK’s R&D tax credit scheme

27-02-2015

The UK BioIndustry Association (BIA) is calling for an extended advance assurance scheme in its response…

FinancialPharmaceuticalUKUK BioIndustry AssociationUnited Kingdom

2014 a record year for Bayer, with pharma fired up by new products

2014 a record year for Bayer, with pharma fired up by new products

27-02-2015

For German pharma major Bayer, 2014 proved to be a record year, with the company notching up sales of…

BayerFinancialGermanyManagementMarijn DekkersPharmaceutical

Ablynx 2014 financial results sees loss decrease thanks to collaborations

Ablynx 2014 financial results sees loss decrease thanks to collaborations

26-02-2015

Belgian drug developer Ablynx has released its 2014 full year results, reporting a decreased loss from…

AblynxBelgiumFinancialMerck & CoPharmaceutical

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

25-02-2015

The proposed bonus for Olivier Brandicourt, the new chief executive of Sanofi has drawn criticism from…

Business FinanceFinancialFrancePharmaceuticalPoliticsSanofi

Valeant fourth-qtr 2014 earnings beat expectations

Valeant fourth-qtr 2014 earnings beat expectations

23-02-2015

Canada’s Valeant Pharmaceutical International posted financial results late Sunday, showing that fourth-quarter…

FinancialPharmaceuticalValeantValeant Pharmaceutical InternationalValeant Pharmaceuticals International

Almirall reports strong 2014 financial results following AstraZeneca transfer

Almirall reports strong 2014 financial results following AstraZeneca transfer

23-02-2015

Almirall, Spain’s largest drugmaker, has continued its upward trend and reported strong results for…

AlmirallEkliraFinancialPharmaceuticalSativexSpain

Indian drugmaker Venus sets out pre-budget expectations

Indian drugmaker Venus sets out pre-budget expectations

19-02-2015

The Union Finance Minister should take his government’s “Make in India” campaign to the next level…

FinancialIndiaPharmaceuticalPoliticsResearchVenus Remedies

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Former pharma execs set up financing strategy partnership

Former pharma execs set up financing strategy partnership

18-02-2015

Three former pharma and health care executives have formed a new partnership to provide strategic support…

Business FinanceFinancialnext20PharmaceuticalUSA

New Zealand’s PHARMAC calls for information on anti-diabetic agents

New Zealand’s PHARMAC calls for information on anti-diabetic agents

12-02-2015

New Zealand’s Pharmaceutical Management Agency, PHARMAC, today revealed it is interested in receiving…

DiabetesFinancialHealthcareNew ZealandPharmaceutical

Recordati's 2014 earnings up 20%

Recordati's 2014 earnings up 20%

12-02-2015

Italian pharma company Recordati saw earnings for 2014 soar by 20%, and is aiming to hit 1 billion euros…

FinancialGenerally Accepted Accounting PrinciplesItalyPharmaceuticalRecordati

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

10-02-2015

Following a less than flattering financial performance in 2014, UK pharma major GlaxoSmithKline is realigning…

FinancialGlaxoSmithKlineOncologyPharmaceuticalRespiratory and Pulmonary

Ukraine pharma group APRaD appeals 5% VAT on imported medicines

Ukraine pharma group APRaD appeals 5% VAT on imported medicines

09-02-2015

Ukraine’s Association of Pharmaceutical Research and Development (APRaD) in cooperation with the American…

FinancialPharmaceuticalPoliticsUkraine

ALK Abello 2014 earnings rocket 76%

ALK Abello 2014 earnings rocket 76%

09-02-2015

Denmark-based allergy specialist ALK Abello posted financials this morning, saying it has achieved one…

ALK AbelloAustraliabioCSLCSL LtdFinancialLicensingNew ZealandPharmaceuticalRespiratory and PulmonarySouth Australia

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

05-02-2015

Anglo-Swedish drug major AstraZeneca met its upgraded guidance for 2014, though both profits and share…

AstraZenecaCrestorFinancialNexiumPharmaceutical

Sanofi sees sharp rise in 4th-quarter profits; soon to announce CEO appointment

05-02-2015

French pharma major Sanofi (Euronext: SAN) this morning reported fourth-quarter and full-year 2014 financial…

FinancialGenzymeManagementPharmaceuticalSanofi

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

05-02-2015

Anglo-Swedish pharma major AstraZeneca has acquired the rights to Ireland-headquartered generics major…

ActavisAstraZenecaDalirespFinancialPharmaceuticalRespiratory and PulmonaryTudorza PressairUSA

Lundbeck posts 4th-qtr and full-year 2014 loss, but sees brighter future

05-02-2015

Danish CNS specialist Lundbeck (LUN: CO) reported fourth-quarter 2014 sales of 3.25 billion Danish kroner…

FinancialLundbeckNeurologicalPharmaceutical

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

04-02-2015

UK pharma major GlaxoSmithKline saw its shares rise 2.8% to £14.94 shortly after reporting fourth-quarter…

Core EPsFinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

Merck & Co financials hit by patent expiries and strong dollar

Merck & Co financials hit by patent expiries and strong dollar

04-02-2015

US pharma giant Merck & Co reported 2014 financial, showing that revenue for the fourth quarter declined…

FinancialMerck & CoPharmaceutical

Karolinska Institutet establishes research base in Hong Kong and China after record donation

04-02-2015

Sweden’s Karolinska Institutet is to set up its own research base in Hong Kong. This initiative is…

ChinaFinancialPharmaceuticalResearch

1 to 25 of 1092 results

COMPANY SPOTLIGHT

Menarini

Back to top